Antibiotic resistance in future drugs

Gunnar Kahlmeter discusses global efforts to tackle antibiotic resistance and the vital role of the European Committee on Antimicrobial Susceptibility Testing in creating definitions for a global consensus.

Gunnar Kahlmeter discusses global efforts to tackle antibiotic resistance and highlights the vital role of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in creating definitions for a global consensus. Without a consensus, the same microorganism could be deemed ‘susceptible’ in one country and ‘resistant’ in another.

The World Health Organization states that we are in ‘a race against time to develop new antibiotics’. 

Central to on-going global efforts to tackle antimicrobial resistance is the increasingly successful international standardisation of the definition of resistance. Resistance is ‘the likelihood of failure of therapy with a specific agent for a specific organism’ and it is related to a trait inherent in the microorganism. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

AfPP Newcastle Regional Conference

Herschel Building, Newcastle University
26th April 2025

GS1 UK Healthcare Conference

QEII Centre, London Westminster
29th – 30th April 2025

Infection Prevention and Control 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th – 30th April 2025

Decontamination and Sterilisation 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th April 2025

Scottish Intensive Care Society Conference 2025

Crieff Hydro Hotel, Scotland
1st - 2nd May 2025

AfPP Plymouth Regional Conference

TBC, Plymouth
10th May 2025